Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Travoprost vs Tafluprost in Glaucoma or Ocular Hypertension
NCT00966940Phase 4Completed
- Sponsor
- Alcon Inc.
- Start
- Sep 2009
- Primary completion
- Mar 2010
- Modality
- Prodrugs/Conditional Activator Small Molecules
01
Overview
Phase 4, randomised, double-blind trial of travoprost in primary open-angle glaucoma (POAG) and ocular hypertension, sponsored by Alcon Inc. Started Sep 2009; status: completed.
02
Drugs
travoprost
03
Conditions
primary open-angle glaucoma (POAG)ocular hypertension
Beyond the preview
Go deeper on NCT00966940.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00966940.